MIRA INFORM REPORT

 

 

Report Date :

12.07.2007

 

IDENTIFICATION DETAILS

 

Name :

WORLD WIDE PHARMACEUTICALS DISTRIBUTORS

 

 

Registered Office :

P O Box 250X, Lilongwex

 

 

Country :

Malawi

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

2004

 

 

Legal Form :

Partnership Concern

 

 

Line of Business :

Traders and Importers of Pharmaceuticals.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 


 

LOCATIONS

 

Registered Office :

P O Box 250X, Lilongwex, Malawi

Tel. No.:

00265 1724655 – 00265 172 5109

Mobile No.:

00265 1725231

Fax No.:

00 2659 324282 [Mr. Kumar]

E-Mail :

worldwide@africa-online.net

Area :

+ 2000 sq. ft.

Location :

Owned [By Partners]

 

 

PARTNERS

 

Name :

Mr. Abdulla Master

Designation :

Partner

 

 

Name :

Mr.Ayub Patel

Designation :

Partner

 

 

BUSINESS DETAILS

 

Line of Business :

Traders and Importers of Pharmaceuticals.

 

 

Imports :

 

Products :

Pharmaceutical Products

Countries :

Kenya, South Africa, Zambia, U.K. and Malaysia

 

 

Terms :

 

Selling :

Cash and Credit [90 days]

 

 

Purchasing :

D/A, Credit and L/C [120 days]

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers, Retailers, Government, NGO’s, Private Companies, Doctors and Pharmacists

 

 

No. of Employees :

9

 

 

Bankers :

National Bank of Malawi

Lilongwex

 

 

Facilities :

Credit Limit : Up to US$ 1 millions

 

 

 

Banking Relations :

--

 

 

 

 

Associates :

Worldwide Wholesalers

Malawi

Line of business : Transport, Cloth and Agro Business

 

Nyiombo Investments

Malawi

Line of Business : Distributors for fertilizers

 

 

FINANCIAL DATA

[all figures are in US$ Millions]

 

Particulars

 

 

31.03.2008 [Expected]

31.03.2007

Sales Turnover

 

3.400

1.600

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Trade Reference :

 

Ø       Kopran Limited, Mumbai

Ø       Torrent Pharmaceuticals Limited, Ahmedabad

Ø       Claris Lifesciences Limited, Ahmedabad

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions